G. Hatemi Et Al. , "EFFICACY OF APREMILAST FOR ORAL ULCERS ASSOCIATED WITH ACTIVE BEHCET'S SYNDROME OVER 64 WEEKS: RESULTS FROM A PHASE III STUDY," Annual European Congress of Rheumatology (EULAR) , vol.78, Madrid, Spain, pp.148-149, 2019
Hatemi, G. Et Al. 2019. EFFICACY OF APREMILAST FOR ORAL ULCERS ASSOCIATED WITH ACTIVE BEHCET'S SYNDROME OVER 64 WEEKS: RESULTS FROM A PHASE III STUDY. Annual European Congress of Rheumatology (EULAR) , (Madrid, Spain), 148-149.
Hatemi, G., Mahr, A., Takeno, M., Kim, D., Saadoun, D., Direskeneli, H., ... Cheng, S.(2019). EFFICACY OF APREMILAST FOR ORAL ULCERS ASSOCIATED WITH ACTIVE BEHCET'S SYNDROME OVER 64 WEEKS: RESULTS FROM A PHASE III STUDY . Annual European Congress of Rheumatology (EULAR) (pp.148-149). Madrid, Spain
Hatemi, Gülen Et Al. "EFFICACY OF APREMILAST FOR ORAL ULCERS ASSOCIATED WITH ACTIVE BEHCET'S SYNDROME OVER 64 WEEKS: RESULTS FROM A PHASE III STUDY," Annual European Congress of Rheumatology (EULAR), Madrid, Spain, 2019
Hatemi, Gülen Et Al. "EFFICACY OF APREMILAST FOR ORAL ULCERS ASSOCIATED WITH ACTIVE BEHCET'S SYNDROME OVER 64 WEEKS: RESULTS FROM A PHASE III STUDY." Annual European Congress of Rheumatology (EULAR) , Madrid, Spain, pp.148-149, 2019
Hatemi, G. Et Al. (2019) . "EFFICACY OF APREMILAST FOR ORAL ULCERS ASSOCIATED WITH ACTIVE BEHCET'S SYNDROME OVER 64 WEEKS: RESULTS FROM A PHASE III STUDY." Annual European Congress of Rheumatology (EULAR) , Madrid, Spain, pp.148-149.
@conferencepaper{conferencepaper, author={Gülen HATEMİ Et Al. }, title={EFFICACY OF APREMILAST FOR ORAL ULCERS ASSOCIATED WITH ACTIVE BEHCET'S SYNDROME OVER 64 WEEKS: RESULTS FROM A PHASE III STUDY}, congress name={Annual European Congress of Rheumatology (EULAR)}, city={Madrid}, country={Spain}, year={2019}, pages={148-149} }